军事知识服务平台
血清FKN、FSTL1、Mst1水平与冠心病患者冠状动脉狭窄程度、氧化应激及预后的相关性研究
Study on the correlation of serum FKN,FSTL1 and Mst1 levels with the degree of coronary artery stenosis,oxidative stress and prognosis in patients with coronary heart disease
摘要 目的 探讨血清不规则趋化因子(FKN)、卵泡抑素样蛋白-1(FSTL1)、哺乳动物不育系 20 样激酶 1(Mst1)水平与冠心病患者冠状动脉狭窄(CAS)程度、氧化应激及预后的相关性研究.方法 选取 2024 年 1 月—2025年 1 月南京医科大学第四附属医院心血管内科收治的冠心病患者 204 例为冠心病组,将患者根据 Gensini 评分分为轻度亚组 77 例、中度亚组 69 例、重度亚组 58 例;根据预后情况分为良好亚组 152 例和不良亚组 52 例,另选取同期健康体检者 105 例作为健康对照组.ELISA 法检测血清 FKN、FSTL1、Mst1 水平,采用比色法测定超氧化物歧化酶(SOD)、丙二醛(MDA)、谷胱甘肽过氧化酶(GSH-Px)水平;点二列及 Pearson 法分析血清 FKN、FSTL1、Mst1 水平与 CAS 程度、氧化应激指标的相关性;多因素 Logistic 回归分析冠心病患者预后不良的影响因素;ROC 曲线评估血清 FKN、FSTL1、Mst1 水平对冠心病患者预后不良的预测价值.结果 冠心病组血清 FKN、FSTL1、Mst1 水平均高于健康对照组(t/P=58.392/<0.001、43.048/<0.001、45.009/<0.001);轻度亚组、中度亚组、重度亚组患者血清 FKN、FSTL1、Mst1、MDA 水平依次升高,而 SOD、GSH-Px 水平依次降低(F/P=43.568/<0.001、31.507/<0.001、80.499/<0.001、69.392/<0.001、41.234/<0.001、59.089/<0.001);冠心病患者血清 FKN、FSTL1、Mst1 水平与 CAS 程度呈正相关(rpb/P=0.498/<0.001、0.536/<0.001、0.461/<0.001);冠心病患者血清 FKN、FSTL1、Mst1 水平与 MDA 呈正相关(r/P=0.397/<0.001、0.453/<0.001、0.409/<0.001),与 SOD、GSH-Px 呈负相关(r/P=-0.436/<0.001、-0.411/<0.001,-0.417/<0.001、-0.328/<0.001,-0.354/<0.001、-0.442/<0.001);与良好亚组比较,不良亚组多支病变患者比例、Gensini 评分以及 CK-MB、cTnI、MDA、FKN、FSTL1、Mst1 水平升高,SOD、GSH-Px 水平降低(χ2/P=14.794/<0.001,t/P=28.000/<0.001、5.304/<0.001、5.731/<0.001、7.849/<0.001、8.235/<0.001、8.052/<0.001、8.821/<0.001、7.418/<0.001、7.817/<0.001);多支病变、Gensini 评分升高、FKN 升高、FSTL1 升高、Mst1 升高是冠心病患者预后不良的危险因素[OR(95%CI)=2.794(1.215~6.427)、3.758(2.320~6.086)、3.198(1.715~5.964)、3.015(1.545~5.882)、3.364(1.955~5.790)];血清 FKN、FSTL1、Mst1 水平单独及联合预测冠心病患者预后不良的 AUC 分别为 0.813、0.813、0.828、0.934,三者联合高于单一指标预测的 AUC(Z/P=4.018/<0.001、3.192/<0.001、3.713/<0.001).结论 冠心病患者血清 FKN、FSTL1、Mst1 水平升高,且与 CAS 程度、氧化应激及预后相关,三者联合检测可作为预测冠心病患者预后不良的生物学指标.
Abstract:
Objective To investigate the association between serum levels of fractalkine(FKN),follistatin-like protein 1(FSTL1),and mammalian sterile 20-like kinase 1(Mst1)and the severity of coronary artery stenosis(CAS),oxida-tive stress,and prognosis in patients with coronary heart disease(CHD).Methods Between January 2024 and January 2025,204 patients with CHD admitted to the Department of Cardiology at the Fourth Affiliated Hospital of Nanjing Medical Univer-sity were enrolled as the case group.Based on the Gensini score,patients were divided into a mild subgroup(77 cases),a moderate subgroup(69 cases),and a severe subgroup(58 cases).Based on prognosis,patients were further divided into a fa-vorable prognosis subgroup(152 cases)and an unfavorable prognosis subgroup(52 cases).Additionally,105 individuals who underwent health check-ups during the same period were selected as the healthy control group.Serum levels of FKN,FSTL1,and Mst1 were measured by ELISA.Correlation analysis was performed to examine the relationships between serum FKN,FSTL1,and Mst1 levels and the severity of CAS.Multivariate LASSO-logistic regression analysis was used to identify factors associated with unfavorable prognosis in CHD patients.ROC curves were constructed to evaluate the predictive value of serum FKN,FSTL1,and Mst1 individually and in combination for unfavorable prognosis.Results Serum levels of FKN,FSTL1,and Mst1 were significantly higher in the case group than in the healthy control group(t/P=58.392/<0.001,43.048/<0.001,45.009/<0.001).Serum FKN,FSTL1,Mst1,and MDA levels progressively increased across the mild,moderate,and severe subgroups,while SOD and GSH-Px levels progressively decreased(F/P=43.568/<0.001,31.507/<0.001,80.499/<0.001,69.392/<0.001,41.234/<0.001,59.089/<0.001).Serum FKN,FSTL1,and Mst1 levels were positively correlated with the se-verity of CAS(r/P=0.498/<0.001,0.536/<0.001,0.461/<0.001).Serum FKN,FSTL1,and Mst1 were positively correlated with MDA(r/P=0.397/<0.001,0.453/<0.001,0.409/<0.001)and negatively correlated with SOD and GSH-Px(FKN:r/P=-0.436/<0.001,-0.411/<0.001;FSTL1:-0.417/<0.001,-0.328/<0.001;Mst1:-0.354/<0.001,-0.442/<0.001).The un-favorable prognosis subgroup had significantly higher proportions of patients with multiple lesions,as well as higher FKN,FSTL1,Mst1,Gensini scores,CK-MB,cTnI,and MDA levels,while SOD and GSH-Px levels were significantly lower com-pared with the favorable prognosis subgroup(χ2/t/P=14.794/<0.001,8.235/<0.001,8.052/<0.001,8.821/<0.001,28.000/<0.001,5.304/<0.001,5.731/<0.001,7.849/<0.001,7.418/<0.001,7.817/<0.001).Multiple lesions,elevated Gensini score,ele-vated FKN,elevated FSTL1,and elevated Mst1 were independent risk factors for poor prognosis in CHD patients[OR(95%CI)=2.794(1.215-6.427),3.758(2.320-6.086),3.198(1.715-5.964),3.015(1.545-5.882),3.364(1.955-5.790)].The AUCs for serum FKN,FSTL1,Mst1 alone,and their combination for predicting poor prognosis were 0.813,0.813,0.828,and 0.934,respectively.The combined AUC was significantly higher than that of any single marker(Z/P=4.018/<0.001,3.192/<0.001,3.713/<0.001).Conclusion Elevated serum levels of FKN,FSTL1,and Mst1 in CHD patients are associated with the severity of coronary artery stenosis,oxidative stress,and prognosis.The combination of these three markers may serve as a potential biomarker for predicting poor prognosis in patients with CHD.